Medical Devices · Healthcare
CEO, Board Member
Analyst
Global Leader of TMTT
Board Member
Edwards Lifesciences Corp (EW)Equibles does not estimate personal net worth.
Bernard Zovighian is recorded as Analyst at Global Leader of TMTT and CEO and Board Member at Edwards Lifesciences Corp (EW). The newest filing on record that lists Bernard Zovighian as CEO and Board Member at Edwards Lifesciences Corp (EW) is dated March 26, 2026. Bernard Zovighian has spoken on 16 earnings calls and 1 other investor event across 1 company, most recently for Edwards Lifesciences Corp on July 23, 2026. Edwards Lifesciences Corp is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Edwards Lifesciences Corp includes Mr. Mussallem (CEO), Mr. Zovighian (CEO), Mr. Ullem (CFO) and 7 others.
“So, in summary, our second quarter performance underscores the strength of our focus strategy and reinforces our confidence that the investments we are making today will drive sustainable growth and meaningful value creation over the long term. before we move to q a i also like to highlight two upcoming opportunities…”
“Look, it is, you know, we feel good about, you know, where we are at, you know, as a company. and when I step back and I reflect the reason why, I think we have a great strategy, we have strategic clarity it's all about structural heart everybody in the company is focusing on that, we have a great culture the…”
“Building on a year in 2025 marked by solid financial performance and strategic progress, we delivered another strong quarter in Q1, achieving 12.7% sales growth, which reflects the impact and durability of our differentiated strategy.”
“I am pleased to introduce Gerian Sarte as our new head of investor relations at Edwards. Gerian has an extensive background in MedTech and as a leader in a global finance organization prior to moving to this new position.”
“We are pleased with the year-to-date performance of the company, including the most recent third quarter. Our focus on structural heart has positioned us to execute our growth strategy with agility this year and also gives us confidence in 2026 and beyond.”
Global Leader of TMTT
Analyst
Source not stated
Start not stated–present
Last confirmed March 26, 2026
Start not stated–present
Last confirmed March 26, 2026
Proxy statement
Medical Devices · Healthcare
CEO, Board Member